Thu, November 4, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Matt Bryson Initiated (AXTI) at Buy and Held Target at $11 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Insoo Kim Downgraded (AWK) to Hold and Decreased Target to $177 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
David Turkaly Maintained (AXGN) at Buy with Decreased Target to $20 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Justin Kim Maintained (AUPH) at Hold with Increased Target to $33 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Ed Arce Maintained (AUPH) at Strong Buy with Increased Target to $40 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Joseph Schwartz Maintained (AUPH) at Buy with Increased Target to $35 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy with Increased Target to $92 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Danielle Antalffy Maintained (ATRC) at Buy with Increased Target to $110 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Jonathan Yong Maintained (AMED) at Buy with Increased Target to $205 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Scott Fidel Maintained (AMED) at Hold with Increased Target to $185 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Frank Morgan Maintained (AMED) at Buy with Decreased Target to $221 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Whit Mayo Maintained (AMED) at Hold with Increased Target to $181 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Michael Pachter Downgraded (AMC) to Sell and Held Target at $66 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
C. Gregory Peters Downgraded (ALL) to Buy and Decreased Target to $140 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Brad Milsaps Upgraded (CADE) to Buy and Increased Target to $40 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Lauren Silberman Maintained (CAKE) at Hold with Decreased Target to $52 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Brian Vaccaro Maintained (CAKE) at Buy with Decreased Target to $53 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Trey Grooms Maintained (BLD) at Hold with Increased Target to $285 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Kenneth Zener Maintained (BLD) at Buy with Increased Target to $300 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Maurice Choy Maintained (BIP) at Buy with Increased Target to $43 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Brian Nowak Maintained (BKNG) at Hold on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Andrew Boone Maintained (BKNG) at Buy on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Brad Erickson Maintained (BKNG) at Hold on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
James Lee Maintained (BKNG) at Strong Buy on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Patrick O"Shaughnessy Maintained (BR) at Buy with Increased Target to $192 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Joseph Spak Maintained (BWA) at Hold with Decreased Target to $47 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Brian Johnson Maintained (BWA) at Hold with Increased Target to $48 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Jeffrey Stevenson Upgraded (BXC) to Strong Buy and Increased Target to $75 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Andrew Berens Maintained (ZYME) at Hold with Decreased Target to $28 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Mike Matson Maintained (ZBH) at Strong Buy with Decreased Target to $175 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Michael Phillips Maintained (AIZ) at Buy with Increased Target to $191 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Michael King Maintained (AGIO) at Strong Buy with Increased Target to $95 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $14 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Gena Wang Maintained (BCRX) at Buy with Decreased Target to $17 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Michael Cyprys Maintained (APO) at Buy with Increased Target to $90 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Brent Thill Downgraded (ASAN) to Hold and Increased Target to $135 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Justin Patterson Maintained (ANGI) at Buy with Decreased Target to $16 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Ben Bienvenu Upgraded (ANDE) to Buy and Increased Target to $48 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
John Heagerty Downgraded (AON) to Hold and Held Target at $320 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Pearce Hammond Downgraded (AMRC) to Hold and Increased Target to $96 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Neal Dingmann Upgraded (APA) to Strong Buy and Increased Target to $45 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Steven Delaney Maintained (ACRE) at Buy and Held Target at $17 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Rommel Dionisio Maintained (VSTO) at Strong Buy with Increased Target to $57 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Sean Horgan Maintained (VIRT) at Strong Buy with Increased Target to $38 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Christopher Carril Maintained (WING) at Hold with Decreased Target to $158 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Andrew Charles Maintained (WING) at Buy with Decreased Target to $175 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
David George Maintained (WFC) at Buy and Held Target at $50 on, Nov 4th, 2021
[ Thu, Nov 04th 2021 ]: WOPRAI
Samuel Eisner Maintained (WHR) at Strong Buy and Held Target at $280 on, Nov 4th, 2021

Andrew Berens Maintained (ZYME) at Hold with Decreased Target to $28 on, Nov 4th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-28-on-nov-4th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Andrew Berens of SVB Leerink, Maintained "Zymeworks Inc." (ZYME) at Hold with Decreased Target from $43 to $28 on, Nov 4th, 2021.

Andrew has made no other calls on ZYME in the last 4 months.



There is 1 other peer that has a rating on ZYME. Out of the 1 peers that are also analyzing ZYME, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew

  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $44 on, Thursday, August 5th, 2021